Resource centre

This webinar covers a real-world case study with Druggability Technologies, a specialty pharmaceutical company, which utilized Quotient’s integrated approach to advance the development of DRGT-46, a novel, fast-acting formulation of celecoxib, using proprietary super-API compositions developed by DRGT.

This webinar will explore product considerations when designing pediatric pharmaceutical products, clinical and operational considerations when executing and designing clinical trials for pediatric patient populations and regulatory considerations for pediatric drug development including US and EMEA incentives, guidance and requirements.

Overcoming poor drug solubility is a common and challenging task facing the formulation scientist today.

Join industry experts John McDermott, Executive Director of Drug Product Optimization, and Kieran Crowley, Senior Scientific Director, both from Quotient Scienbces, as they outline studies and metrics in drug delivery and drug product optimization.

Increasing pressure on R&D budgets means the design, speed and precision of early phase clinical programs is critical for success.